5
August

IMA ad Achema

Corporate

The IMA Group at ACHEMA 2022

The IMA Group is pleased to announce that its Pharmaceutical divisions will be present at Achema 2022 to show the All-In-One Pharma range of solutions and the following projects aimed at sustainability and digitalisation. IMA ZERO is the evolution of […]

8
March

Manufacturing equipment

Agreement for antiviral biologics low cost production

The antiviral biologic molnupiravir is going to be synthesized in 27
specialized companies for a modest amount of money, and it is going to
supply 105 developing countries

21
February

Manufacturing equipment

Challenges for QP: imports of medicines, vaccines and new technologies

During the second part of the XV Qualificate People meeting, settled by AFI, the main themes have been imports of medicines, challenges due to new technologies and, of course, vaccines

  • 1
  • 2